NEW YORK, May 2 - Ambion is sitting pretty these days. The Austin, Texas-based RNA provider not only finds itself in the center of the RNAi technology explosion, it has the luxury of having raised $10.5 million in venture capital financing this week, just to have in its coffers in case it wants to make an acquisition or expand a business area.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.